/ Home / Product Center / APIs / Anti-Cancer Series /

Baricitinib*

Baricitinib*
CAS
1187594-09-7
MF
C16H17N7O2S
MW
371.42
Purity
98%
Melting point
212-215°C
Solubility
Soluble in DMSO (up to 30 mg/ml) or in DMF (up to 50 mg/ml).
Appearance
White or off-white solid
Storage Temp
-20°C
Indication
Anti-cancer
Description

Baricitinib (1187594-09-7), approved by the FDA for two inflammatory disorders, rheumatoid arthritis and alopecia areata, selectively inhibits Janus kinase 1 (IC50?= 5.9 nM) and 2 (5.7 nM), over 3 (0.56 μM).1

Documents

DMF2024Q3